AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 1 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $28,000 | +12.0% | 3,550 | +91.9% | 0.00% | 0.0% |
| Q3 2017 | $25,000 | -82.5% | 1,850 | -84.8% | 0.00% | -83.3% |
| Q2 2017 | $143,000 | -33.8% | 12,150 | -39.7% | 0.01% | -33.3% |
| Q1 2017 | $216,000 | +20.7% | 20,150 | +113.2% | 0.01% | +50.0% |
| Q4 2016 | $179,000 | -27.8% | 9,450 | -70.4% | 0.01% | -45.5% |
| Q3 2016 | $248,000 | -76.6% | 31,886 | -69.3% | 0.01% | -79.6% |
| Q2 2016 | $1,061,000 | +584.5% | 103,948 | +143.7% | 0.05% | +440.0% |
| Q1 2016 | $155,000 | -40.4% | 42,653 | +47.4% | 0.01% | -33.3% |
| Q4 2015 | $260,000 | – | 28,946 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 4,060,000 | $46,893,000 | 3.11% |
| Camber Capital Management LP | 4,390,000 | $50,705,000 | 2.67% |
| Palo Alto Investors LP | 3,078,874 | $35,561,000 | 2.37% |
| Permanens Capital L.P. | 407,811 | $4,710,000 | 1.32% |
| Fondren Management LP | 35,000 | $404,000 | 0.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 33,524 | $387,000 | 0.29% |
| BOOTHBAY FUND MANAGEMENT, LLC | 240,000 | $2,772,000 | 0.25% |
| Broadfin Capital, LLC | 100,000 | $1,155,000 | 0.21% |
| FOX RUN MANAGEMENT, L.L.C. | 13,687 | $158,000 | 0.14% |
| Spark Investment Management LLC | 92,200 | $1,064,000 | 0.14% |